IBDEI3I6 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=SEXUAL TRAUMA^32^68
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^68
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^68
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=SUBSTANCE DISORDERS^35^68
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=VARICOSE VEINS^36^68
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=WOMEN'S HEALTH^37^68
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^38^68
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=COMA^7^68
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=CAUSES OF INJURY^6^68
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=DEMENTIA^8^68
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^24^68
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=ESTABLISHED PATIENT^2^69
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=WORK/DISABILITY^1^69
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=NEW PATIENT^3^69
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=IMMUNIZATION^2^70
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=SKIN TEST^8^70
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=LACERATION REPAIR/SUTURES^3^70
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=OTHER^4^70
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=FOREIGN BODY REMOVAL^1^70
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=PREVENTIVE MEDICINE-EST PT^5^70
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^6^70
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=SCREENING RESULTS^7^70
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=INJURIES^7^71
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=EMPLOYEE HEALTH COMMON DX^1^71
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=EXAMINATIONS^4^71
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=EXPOSURES^5^71
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=IMMUNIZATIONS^6^71
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=CARDIOVASCULAR EXERCISE^2^71
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=COUNSELING^3^71
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=MUSCLE CONDITIONING EXERCISE^8^71
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=NEW PATIENT^2^72
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=ESTABLISHED PATIENT^1^72
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=CONSULTATIONS^3^72
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=BIOPSIES^1^73
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=INJECTIONS^2^73
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=OTHER^3^73
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=ENDOCRINE DX^1^74
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=HEAD AND NECK-MISCELLANEOUS^1^75
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=NOSE AND SINUSES^3^75
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=ORAL CAVITY^4^75
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=OTOLOGY^5^75
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=PHARYNX AND LARYNX^6^75
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=MISCELLANEOUS PROCEDURES^2^75
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=ESTABLISHED PATIENT^1^76
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=CONSULTATIONS^3^76
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=NEW PATIENT^2^76
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=POST OP^4^76
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=ALIMENTARY TRACT^1^77
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=FRACTURES^2^77
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=NEOPLASMS^4^77
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=RESPIRATORY TRACT^6^77
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=OTOLOGY^5^77
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=OTHER HEAD AND NECK^7^77
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=METASTATIC SITES^3^77
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=NEW PATIENT^3^78
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=ESTABLISHED PATIENT^2^78
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=CONSULTATIONS^4^78
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=EYE CODES^1^78
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=REFRACTION^7^79
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=GLASSES/CONTACT LENSES^2^79
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=SPECIAL OPHTHALMIC SERVICES^9^79
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=PROCEDURES^6^79
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=LASER PROCEDURES^4^79
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=RETINA PROCEDURES^8^79
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=MEDICATIONS^5^79
